AI NewsMedical TechnologyRegulatory Compliance
FDA Upgrades J&J MedTech CEREPAK Recall to Class I After Fatal Incident
The FDA classifies J&J MedTech’s CEREPAK recall as Class I, the most serious level, after a fatal embolic event linked to device failure.